Sign in

CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203857670
Phone
844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
  1. 4 Open-market buy Director bought 70,000 shares at $2.67 ($187,082)
  2. 4 Open-market buy President and CEO bought 18,050 shares at $2.77 ($49,953)
  3. 4 Open-market buy Director bought 8,000 shares at $2.73 ($21,800)
  4. 4 Open-market buy Director bought 3,500 shares at $2.80 ($9,792)
  5. 4 Open-market buy President and COO bought 17,800 shares at $2.80 ($49,918)
  6. 4 Open-market buy Chief Financial Officer bought 18,460 shares at $2.71 ($49,992)
  7. 4 Open-market buy Chief Development Officer bought 5,000 shares at $2.71 ($13,549)
  8. 4 Insider Changes in Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 1 of 14 · 271 filings